Witzig, T. E., Tang, H., Micallef, I. N. M., Ansell, S. M., Link, B. K., Inwards, D. J., . . . Kaufmann, S. H. (2011). Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas. American Society of Hematology.
Citação norma ChicagoWitzig, Thomas E., et al. Multi-institutional Phase 2 Study of the Farnesyltransferase Inhibitor Tipifarnib (R115777) in Patients With Relapsed and Refractory Lymphomas. American Society of Hematology, 2011.
Citação norma MLAWitzig, Thomas E., et al. Multi-institutional Phase 2 Study of the Farnesyltransferase Inhibitor Tipifarnib (R115777) in Patients With Relapsed and Refractory Lymphomas. American Society of Hematology, 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.